Journal of Medicinal Chemistry · 2014 · 15 citations · 12 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyDrug-receptor InteractionsLigand BindingMolecular DockingProtein-ligand DockingReceptor PharmacologyReceptor-ligand InteractionsAgonist ActivityBenzoic Acid DerivativesDocking-based Drug DesignGpcr SelectivityLigand Design For ReceptorsProtective Barrier FunctionReceptor Binding OptimizationStructure-based Ligand Design
Lysophosphatidic acid (LPA) is a growth factor-like mediator and a ligand for multiple GPCR. The LPA2 GPCR mediates antiapoptotic and mucosal barrier-protective effects in the gut. We synthesized sulfamoyl benzoic acid (SBA) analogues that are the first specific agonists of LPA2, some with subnanomolar activity. We developed an experimental SAR that is supported and rationalized by computational docking analysis of the SBA compounds into the LPA2 ligand-binding pocket.
12
Yuko Fujiwara, Vineet M. Sardar, Akira Tokumura et al. · Journal of Biological Chemistry · 2005 · 90 citations · Full text